HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus.

Abstract
Apheresis has been effective as rescue therapy in patients with severe, therapy-resistant, systemic lupus erythematosus (SLE). Its benefit in patients with less severe but therapy-resistant SLE is not known. Dextran sulfate apheresis was applied as a rescue therapy for therapy-resistant vasculitic skin lesions in a 30 year old female patient with a 9 year history of SLE in combination with antiphospholipid syndrome and Raynaud's phenomenon. Partial remission was achieved after 9 immunoadsorption sessions, as documented by marked improvement of skin lesions and an increase of capillary density in the nailfold area. Further improvement was noted with maintenance therapy using mycophenolate mofetil. Dextran sulfate apheresis can be applied safely in patients with moderate therapy-resistant SLE disease activity when severe immunodeficiency and cytotoxic adverse effects should be avoided.
AuthorsNorbert Braun, Michael Jünger, Reinhild Klein, Sylvia Gutenberger, Michael Guagnin, Teut Risler
JournalTherapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis (Ther Apher) Vol. 6 Issue 6 Pg. 471-7 (Dec 2002) ISSN: 1091-6660 [Print] United States
PMID12460414 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • Immunoglobulins
  • Immunosuppressive Agents
  • Complement System Proteins
  • Dextran Sulfate
  • Mycophenolic Acid
Topics
  • Adsorption
  • Adult
  • Antibodies, Antinuclear (blood)
  • Blood Component Removal
  • Complement System Proteins (analysis)
  • Dextran Sulfate
  • Female
  • Fingers (blood supply)
  • Humans
  • Immunoglobulins (blood)
  • Immunosuppressive Agents (therapeutic use)
  • Lupus Erythematosus, Systemic (complications, immunology, pathology, therapy)
  • Microscopic Angioscopy
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Plasmapheresis
  • Skin Diseases, Vascular (complications, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: